Joel Isaacson & Co. LLC boosted its stake in shares of CVS Well being Co. (NYSE:CVS – Free Report) by 57.6% throughout the third quarter, in accordance with its most up-to-date disclosure with the SEC. The institutional investor owned 5,473 shares of the pharmacy operator’s inventory after buying an extra 2,000 shares throughout the interval. Joel Isaacson & Co. LLC’s holdings in CVS Well being have been value $344,000 on the finish of the latest reporting interval.
A number of different massive traders have additionally lately added to or diminished their stakes within the inventory. Capital World Buyers elevated its stake in shares of CVS Well being by 8.0% within the first quarter. Capital World Buyers now owns 43,776,874 shares of the pharmacy operator’s inventory value $3,491,643,000 after buying an extra 3,232,172 shares over the past quarter. Capital Worldwide Buyers raised its stake in shares of CVS Well being by 12.5% throughout the 1st quarter. Capital Worldwide Buyers now owns 37,917,923 shares of the pharmacy operator’s inventory value $3,024,334,000 after buying an extra 4,226,225 shares within the final quarter. Capital Analysis World Buyers lifted its holdings in shares of CVS Well being by 1.4% throughout the 1st quarter. Capital Analysis World Buyers now owns 13,143,822 shares of the pharmacy operator’s inventory valued at $1,048,351,000 after shopping for an extra 184,297 shares over the past quarter. Pzena Funding Administration LLC grew its stake in shares of CVS Well being by 132.9% within the 2nd quarter. Pzena Funding Administration LLC now owns 12,936,388 shares of the pharmacy operator’s inventory valued at $764,023,000 after shopping for an extra 7,382,931 shares within the final quarter. Lastly, Lazard Asset Administration LLC elevated its holdings in CVS Well being by 5.9% within the first quarter. Lazard Asset Administration LLC now owns 6,963,508 shares of the pharmacy operator’s inventory value $555,406,000 after shopping for an extra 389,166 shares over the past quarter. Institutional traders and hedge funds personal 80.66% of the corporate’s inventory.
Analysts Set New Value Targets
A number of analysts have commented on the inventory. Mizuho decreased their goal worth on shares of CVS Well being from $73.00 to $66.00 and set an “outperform” ranking for the corporate in a analysis report on Thursday. Cantor Fitzgerald reissued a “impartial” ranking and set a $62.00 goal worth on shares of CVS Well being in a analysis report on Tuesday, October 1st. Truist Monetary boosted their worth goal on CVS Well being from $66.00 to $76.00 and gave the inventory a “purchase” ranking in a analysis report on Friday, October eleventh. Royal Financial institution of Canada reissued an “outperform” ranking and set a $68.00 worth goal on shares of CVS Well being in a report on Wednesday, September 4th. Lastly, TD Cowen raised CVS Well being from a “maintain” ranking to a “purchase” ranking and upped their goal worth for the inventory from $59.00 to $85.00 in a analysis report on Friday, October 4th. 9 equities analysis analysts have rated the inventory with a maintain ranking and 13 have issued a purchase ranking to the corporate. In response to information from MarketBeat, CVS Well being presently has a consensus ranking of “Average Purchase” and a consensus goal worth of $74.58.
View Our Newest Report on CVS Well being
CVS Well being Buying and selling Up 0.7 %
Shares of CVS Well being inventory opened at $56.49 on Friday. The corporate’s fifty day shifting common worth is $59.82 and its two-hundred day shifting common worth is $59.92. The agency has a market capitalization of $71.06 billion, a PE ratio of 10.05, a price-to-earnings-growth ratio of 0.84 and a beta of 0.54. CVS Well being Co. has a 52-week low of $52.77 and a 52-week excessive of $83.25. The corporate has a debt-to-equity ratio of 0.83, a present ratio of 0.86 and a fast ratio of 0.66.
CVS Well being (NYSE:CVS – Get Free Report) final introduced its quarterly earnings outcomes on Wednesday, August seventh. The pharmacy operator reported $1.83 EPS for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. CVS Well being had a web margin of 1.98% and a return on fairness of 12.72%. The agency had income of $91.23 billion throughout the quarter, in comparison with analysts’ expectations of $91.41 billion. Throughout the identical quarter final 12 months, the corporate earned $2.21 earnings per share. The corporate’s income for the quarter was up 2.6% in comparison with the identical quarter final 12 months. On common, analysts count on that CVS Well being Co. will submit 6.41 EPS for the present 12 months.
CVS Well being Declares Dividend
The corporate additionally lately introduced a quarterly dividend, which will likely be paid on Friday, November 1st. Stockholders of report on Monday, October twenty first will likely be paid a $0.665 dividend. The ex-dividend date of this dividend is Monday, October twenty first. This represents a $2.66 annualized dividend and a dividend yield of 4.71%. CVS Well being’s dividend payout ratio is presently 47.33%.
CVS Well being Profile
CVS Well being Company gives well being options in america. It operates via Well being Care Advantages, Well being Providers, and Pharmacy & Shopper Wellness segments. The Well being Care Advantages section affords conventional, voluntary, and consumer-directed medical health insurance merchandise and associated companies.
Additional Studying
Wish to see what different hedge funds are holding CVS? Go to HoldingsChannel.com to get the newest 13F filings and insider trades for CVS Well being Co. (NYSE:CVS – Free Report).
Obtain Information & Rankings for CVS Well being Day by day – Enter your e-mail handle beneath to obtain a concise every day abstract of the newest information and analysts’ rankings for CVS Well being and associated firms with MarketBeat.com’s FREE every day e-mail publication.
